# ENALAPRILAT

NDC: 51662-1477
Generic name: ENALAPRILAT
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20200201

FDA application: ANDA078687

## Active ingredients

- ENALAPRILAT: 1.25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1477"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1477
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d88f915-13dd-5463-e053-2a95a90a09bf